(Q44898893)

7 December 2017

title

Soluble Arctic amyloid beta protein inhibits hippocampal long-term potentiation in vivo (English)

1 reference

7 December 2017

main subject

long-term potentiation

1 reference

Michael J Rowan

7

0 references

Dennis J. Selkoe

6

object named as

Dennis J Selkoe

1 reference

7 December 2017

Igor Klyubin

1

1 reference

7 December 2017

Dominic M Walsh

2

1 reference

7 December 2017

William K Cullen

3

1 reference

7 December 2017

Julia V Fadeeva

4

1 reference

7 December 2017

Roger Anwyl

5

1 reference

7 December 2017

language of work or name

English

0 references

publication date

1 May 2004

1 reference

European Journal of Neuroscience

7 December 2017

published in

1 reference

7 December 2017

volume

19

1 reference

7 December 2017

issue

10

1 reference

7 December 2017

page(s)

2839-2846

1 reference

Emerging Alzheimer's disease therapies: inhibition of beta-secretase

7 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2004.03389.X

Mutation of the beta-amyloid precursor protein in familial Alzheimer's disease increases beta-protein production

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2004.03389.X

Effects of the mutations Glu22 to Gln and Ala21 to Gly on the aggregation of a synthetic fragment of the Alzheimer's amyloid beta/A4 peptide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2004.03389.X

Oligomeric and fibrillar species of amyloid-beta peptides differentially affect neuronal viability.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2004.03389.X

Flemish and Dutch mutations in amyloid beta precursor protein have different effects on amyloid beta secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2004.03389.X

Peripheral anti-A beta antibody alters CNS and plasma A beta clearance and decreases brain A beta burden in a mouse model of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2004.03389.X

Comparison of the aggregation properties, secondary structure and apoptotic effects of wild-type, Flemish and Dutch N-terminally truncated amyloid beta peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2004.03389.X

Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2004.03389.X

Alzheimer's disease-affected brain: presence of oligomeric A beta ligands (ADDLs) suggests a molecular basis for reversible memory loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2004.03389.X

Amyloid deposition as the central event in the aetiology of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2004.03389.X

Models of amyloid seeding in Alzheimer's disease and scrapie: mechanistic truths and physiological consequences of the time-dependent solubility of amyloid proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2004.03389.X

APP processing and synaptic function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2004.03389.X

Quantitative evaluation of congo red binding to amyloid-like proteins with a beta-pleated sheet conformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2004.03389.X

Behavioral disturbances without amyloid deposits in mice overexpressing human amyloid precursor protein with Flemish (A692G) or Dutch (E693Q) mutation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2004.03389.X

Structural imaging in cognitive impairment and the dementias: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2004.03389.X

Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2004.03389.X

Mixtures of wild-type and a pathogenic (E22G) form of Abeta40 in vitro accumulate protofibrils, including amyloid pores.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2004.03389.X

Amyloid precursor protein (APP) and the biology of proteolytic processing: relevance to Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2004.03389.X

Drugs targeting Alzheimer's disease: some things old and some things new.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2004.03389.X

Substitution at codon 22 reduces clearance of Alzheimer's amyloid-beta peptide from the cerebrospinal fluid and prevents its transport from the central nervous system into blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2004.03389.X

Differential degradation of amyloid beta genetic variants associated with hereditary dementia or stroke by insulin-degrading enzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2004.03389.X

Synthesis, aggregation, neurotoxicity, and secondary structure of various A beta 1-42 mutants of familial Alzheimer's disease at positions 21-23.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2004.03389.X

Neurotoxicity and physicochemical properties of Abeta mutant peptides from cerebral amyloid angiopathy: implication for the pathogenesis of cerebral amyloid angiopathy and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2004.03389.X

Dementia in hereditary cerebral hemorrhage with amyloidosis-Dutch type is associated with cerebral amyloid angiopathy but is independent of plaques and neurofibrillary tangles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2004.03389.X

The 'Arctic' APP mutation (E693G) causes Alzheimer's disease by enhanced Abeta protofibril formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2004.03389.X

Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2004.03389.X

Degradation of soluble amyloid beta-peptides 1-40, 1-42, and the Dutch variant 1-40Q by insulin degrading enzyme from Alzheimer disease and control brains.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2004.03389.X

Insulin-degrading enzyme regulates extracellular levels of amyloid beta-protein by degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2004.03389.X

Synaptic plasticity in animal models of early Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2004.03389.X

The molecular pathology of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2004.03389.X

Alzheimer's disease is a synaptic failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2004.03389.X

The Arctic Alzheimer mutation enhances sensitivity to toxic stress in human neuroblastoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2004.03389.X

Oligomerization of beta-amyloid of the Alzheimer's and the Dutch-cerebral-haemorrhage types

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2004.03389.X

Dutch, Flemish, Italian, and Arctic mutations of APP and resistance of Abeta to physiologically relevant proteolytic degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2004.03389.X

Roles of amyloid precursor protein and its fragments in regulating neural activity, plasticity and memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2004.03389.X

Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2004.03389.X

Amyloid beta-protein fibrillogenesis. Detection of a protofibrillar intermediate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2004.03389.X

Soluble oligomers of beta amyloid (1-42) inhibit long-term potentiation but not long-term depression in rat dentate gyrus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2004.03389.X

Effects of the amyloid precursor protein Glu693-->Gln 'Dutch' mutation on the production and stability of amyloid beta-protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2004.03389.X

Familial cerebral amyloid angiopathy presenting as recurrent cerebral haemorrhage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2004.03389.X

Spatial exploration induces a persistent reversal of long-term potentiation in rat hippocampus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2004.03389.X

A pathogenic mutation for probable Alzheimer's disease in the APP gene at the N-terminus of beta-amyloid

21 January 2018

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/citations/10.1038/NG0892-345

Identifiers

DOI

10.1111/J.1460-9568.2004.03389.X

1 reference

release_zle7lojhmzhvphafpe4ipmw3ra

7 December 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/zle7lojhmzhvphafpe4ipmw3ra

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference